Head-to-head · WeighScore
Lean Rx vs Prime Doctor RX
The verdict
Prime Doctor RX takes it — 73/100 to 60.6/100.
Prime Doctor RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its whole ladder and honors its own asterisk — then bills every 28 days and labels every price per month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Lean Rx | Prime Doctor RX |
|---|---|---|
| WeighScore | 60.6/100 | 73/100 |
| Grade | C | C |
| Scorecard rank | #355 | #84 |
| Semaglutide | $266/mo (starting dose, compounded) | $249 every 4 weeks (thirteen charges a year, not twelve) |
| Tirzepatide | $399/mo (starting dose, compounded) | $339 every 4 weeks (thirteen charges a year, not twelve) |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #355 · C
Strengths
- Both semaglutide and tirzepatide offered
- Three formulations: injectable, sublingual, and tablet
- Upfront pricing with no hidden fees advertised
- Semaglutide starts at a low $266/month
- Telehealth call with a licensed provider before prescribing
Where it loses points
- Compounded-only; no FDA-approved branded options
- No published state availability list
- Platform is technology only, not a healthcare provider itself
- Provider credentials not detailed on site
Graded #84 · C
Strengths
- The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
- The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
- The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
- Names OpenLoop Health as the group providing telehealth evaluation and prescribing
- Hormone-care initial labs are priced at $50 rather than left unstated
Where it loses points
- Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
- A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
- The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
- The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
- The $50 lab fee sits in a "how it works" step rather than in the pricing table
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.